WA-AMAZON.COM-INC.
21.9.2022 15:11:03 CEST | Business Wire | Press release
Amazon (NASDAQ: AMZN) announced that it is expanding its renewable energy portfolio globally, with an additional 2.7 gigawatts (GW) of clean energy capacity across 71 new renewable energy projects. This includes the company’s first renewable energy project in South America—a solar farm in Brazil—and its first solar farms in India and Poland. Once fully operational, Amazon’s global renewable energy portfolio will generate 50,000 gigawatt hours (GWh) of clean energy, which is the equivalent amount of electricity needed to power 4.6 million U.S. homes each year.
“We are bringing new wind and solar projects online to power our offices, fulfillment centers, data centers, and stores, which collectively serve millions of customers globally, and we are on a path to reach 100% renewable energy across our entire business by 2025,” said Adam Selipsky, CEO of Amazon Web Services. “Around the world, countries are looking to accelerate the transition to a clean energy economy, and continued investments like ours can help accelerate their journey as we all work together to mitigate the impacts of climate change.”
As the largest corporate purchaser of renewable energy globally, Amazon now has a total of 379 renewable energy projects across 21 countries, including 154 wind and solar farms and 225 rooftop solar projects, representing 18.5 GW of renewable energy capacity. By the end of 2021, the company had reached 85% renewable energy across its business.
Amazon continues to successfully enable projects in power grids around the world, including:
- In the Asia-Pacific region, Amazon is announcing the company’s first three large-scale projects in India. All three are solar projects in Rajasthan, representing 420 megawatts (MW) of clean energy capacity. Amazon is scaling fast in India, and these first investments play a critical role in reducing our carbon emissions in the country. In the Asia-Pacific region, the company now has a total of 57 renewable energy projects.
- In Europe, Amazon now has 117 renewable energy projects. Amazon is announcing its first rooftop solar projects in France and Austria, and its first solar farm in Poland. Amazon’s investment in its first utility-scale project in Poland is one of the largest corporate solar deals announced to date in the country. With this commitment, Amazon is directly contributing to the Polish government’s goal of increasing renewable energy on its grid. Corporate support of new renewable energy projects like Amazon’s helps open up the market for additional wind and solar farms, and accelerates the decarbonization of the grid.
- In North America, Amazon is adding 1 GW of clean energy capacity across the Southeastern U.S., including the company’s first two renewable energy projects in Louisiana. The company now has a total of 202 projects across North America.
- In South America, Amazon is announcing its first renewable energy project, which is a 122 MW solar farm in Brazil. In addition to providing renewable power to Amazon’s operations in the region, this project will also provide economic benefits to the local economy and the region’s biodiversity. The project includes a $380,000 (R$2 million) investment in environmental programs during construction to protect and promote biodiversity. The project is estimated to create 850 jobs during the construction phase, with an additional 30 permanent jobs once the project becomes operational.
To help scale the benefits of investments in the renewable energy sector as it continues to grow, Amazon is also working through the Clean Energy Buyers Institute’s (CEBI) Beyond the Megawatt initiative to ensure the industry is maximizing the economic, environmental, and social impact of energy procurement.
“As a key leader in the CEBA community, Amazon continues to demonstrate that when it commits to a vision, it drives a pace and scale that’s a new bar to follow,” said Miranda Ballentine, CEO of Clean Energy Buyers Association (CEBA) and Clean Energy Buyers Institute (CEBI). “Amazon also continues to be a leader in not only deploying today’s clean energy procurement tools at scale, but also in leading its community of peers and partners in developing tomorrow’s clean energy solutions—whether that’s focusing on ensuring renewables have sustainable supply chains or expanding the impact of clean energy through next generation procurement tools.”
“With its landmark solar projects announced in Poland and France, Amazon has taken crucial steps towards its net-zero pledge, while supporting Europe’s own climate goals,” said Walburga Hemetsberger, CEO of SolarPower Europe, founding partner of the RE-Source Platform. “As Europe faces skyrocketing energy prices, solar and renewable energy deals will strengthen Amazon’s strategic resilience—we hope to see more companies follow Amazon’s lead.”
Amazon co-founded The Climate Pledge in 2019, committing to reach net-zero carbon by 2040—10 years ahead of the Paris Agreement. The Pledge now has more than 375 signatories, including Best Buy, IBM, Microsoft, PepsiCo, Siemens, Unilever, Verizon, and Visa. Amazon has also ordered 100,000 electric delivery vehicles, the largest order ever of electric delivery vehicles, and has started to roll them out across the U.S. The company is also investing $2 billion in the development of decarbonizing services and solutions through The Climate Pledge Fund. For more information, visit https://sustainability.aboutamazon.com/.
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth’s Most Customer-Centric Company, Earth’s Best Employer, and Earth’s Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.
About Amazon Web Services
For over 15 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud offering. AWS has been continually expanding its services to support virtually any cloud workload, and it now has more than 200 fully featured services for compute, storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 87 Availability Zones within 27 geographic regions, with announced plans for 21 more Availability Zones and seven more AWS Regions in Australia, Canada, India, Israel, New Zealand, Spain, and Switzerland. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220921005397/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
